This
technology describes compositions and methods for controllable local delivery of
therapeutic agents to promote bone formation. This technology can be used to
develop treatments for clinical indications such as osteoporosis, bone cancer
and fractures.
This
technology can be honed so that the therapeutic agents are specifically targeted
to a site in need of bone formation.